Shavit Capital
Shavit Capital Fund is a private equity fund investing primarily in small and medium sized Israeli companies.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Shavit Capital Information
Geographic Data
Address: Jerusalem Technology Park
City:
State: jerusalem district
Zip: 96951
Country: IL
Financial Info
Stage:
Raised Last:
$0
Raised Total:$175M
Social
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Shavit Capital Fund is a private equity fund investing primarily in Israeli related companies with a clear path to an IPO (mezzanine rounds) and public companies traded in the US, Israel or other international markets (PIPE/secondary offerings). The Fund seeks investment opportunities in successful, small to medium-sized companies with strong management teams and demonstrated growth potential
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 9/2018 | Alpha Tau Medical | Series A | 0 |
| 1/2022 | MeMed | Venture Round | 0 |
| 8/2017 | Mapi Pharma | Equity | 10M |
| 6/2020 | Alpha Tau Medical | Series B | 0 |
| 6/2021 | KAHR medical | Venture Round | 0 |
| 4/2018 | Anchiano Therapeutics | Post-IPO Equity | 0 |
| 2/2016 | PolyPid | Series D | 0 |
| 6/2017 | Gamida Cell | Series F | 0 |
| 3/2021 | Veev | Series C | 0 |
| 1/2019 | Syqe Medical | Private Equity Round | 0 |
| 9/2021 | Lightricks | Series D | 0 |
| 1/2022 | MeMed | Venture Round | 0 |
| 9/2021 | Lightricks | Series D | 0 |
| 6/2021 | KAHR medical | Venture Round | 0 |
| 3/2021 | Veev | Series C | 0 |
| 6/2020 | Alpha Tau Medical | Series B | 0 |
| 1/2019 | Syqe Medical | Private Equity Round | 0 |
| 9/2018 | Alpha Tau Medical | Series A | 0 |
| 4/2018 | Anchiano Therapeutics | Post-IPO Equity | 0 |
| 6/2017 | Gamida Cell | Series F | 0 |
| 2/2016 | PolyPid | Series D | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
